Annual Long Term Debt
$4.05 M
-$478.20 K-10.55%
31 December 2023
Summary:
SAB Biotherapeutics annual long term debt is currently $4.05 million, with the most recent change of -$478.20 thousand (-10.55%) on 31 December 2023. During the last 3 years, it has fallen by -$2.41 million (-37.32%). SABS annual long term debt is now -37.32% below its all-time high of $6.47 million, reached on 31 December 2020.SABS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$4.00 M
-$135.50 K-3.28%
30 September 2024
Summary:
SAB Biotherapeutics quarterly long term debt is currently $4.00 million, with the most recent change of -$135.50 thousand (-3.28%) on 30 September 2024. Over the past year, it has increased by +$543.10 thousand (+15.73%). SABS quarterly long term debt is now -38.23% below its all-time high of $6.47 million, reached on 31 December 2020.SABS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.6% | +15.7% |
| 3 y3 years | -37.3% | - |
| 5 y5 years | - | - |
SABS Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -37.3% | at low | -26.2% | +15.7% |
| 5 y | 5 years | -37.3% | at low | -38.2% | +15.7% |
| alltime | all time | -37.3% | at low | -38.2% | +15.7% |
SAB Biotherapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.00 M(-3.3%) |
| June 2024 | - | $4.13 M(+4.9%) |
| Mar 2024 | - | $3.94 M(-2.9%) |
| Dec 2023 | $4.05 M(-10.6%) | $4.05 M(+17.4%) |
| Sept 2023 | - | $3.45 M(-16.2%) |
| June 2023 | - | $4.12 M(-5.6%) |
| Mar 2023 | - | $4.37 M(-3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $4.53 M(-16.3%) | $4.53 M(+2.4%) |
| Sept 2022 | - | $4.43 M(-7.0%) |
| June 2022 | - | $4.76 M(-6.5%) |
| Mar 2022 | - | $5.09 M(-6.1%) |
| Dec 2021 | $5.42 M(-16.3%) | $5.42 M(-5.9%) |
| June 2021 | - | $5.76 M(-11.0%) |
| Dec 2020 | $6.47 M(+13.7%) | $6.47 M |
| Dec 2019 | $5.69 M | - |
FAQ
- What is SAB Biotherapeutics annual long term debt?
- What is the all time high annual long term debt for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual long term debt year-on-year change?
- What is SAB Biotherapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly long term debt year-on-year change?
What is SAB Biotherapeutics annual long term debt?
The current annual long term debt of SABS is $4.05 M
What is the all time high annual long term debt for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual long term debt is $6.47 M
What is SAB Biotherapeutics annual long term debt year-on-year change?
Over the past year, SABS annual long term debt has changed by -$478.20 K (-10.55%)
What is SAB Biotherapeutics quarterly long term debt?
The current quarterly long term debt of SABS is $4.00 M
What is the all time high quarterly long term debt for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly long term debt is $6.47 M
What is SAB Biotherapeutics quarterly long term debt year-on-year change?
Over the past year, SABS quarterly long term debt has changed by +$543.10 K (+15.73%)